Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absolute, Aid, ALT, anemic, apparent, ASH, AST, Banc, band, baseline, Biden, bilirubin, binding, Bio, biomarker, biopsy, biosafety, biosimilar, blot, BM, BPCIA, bridging, Britain, British, cap, capita, carryback, Cedarbrook, cgtp, chest, clock, cloud, cohort, Columbia, commandeered, communicable, concomitant, conditionally, confirmatory, constitutionality, constrain, conventional, covertly, creatine, custody, cutoff, database, deploy, Description, distancing, diverge, dividend, dL, dominant, driven, dyspnea, economy, eculizumab, elapsed, electorate, elevated, Elevation, eleven, endocrine, endomyocardial, England, eruption, erythropoietin, ESID, evidenced, experimental, explanation, faster, feel, fluid, foreseen, formally, foundation, fulfilled, fulfilment, furlough, FYs, genome, GOSH, graph, Great, guilty, hallmark, hepcidin, Hgb, hinder, HIV, hypertriglyceridemia, IBC, immunohistochemistry, immunosuppressive, implantation, implanted, importantly, imprisonment, improperly, inclusive, Incomplete, ineligibility, Inferior, Influenza, inhaled, injury, inline, inspired, instilled, Interactive, Interchangeability, interchangeable, invasive, Ireland, Irish, joined, judgement, kg, kidney, licensure, light, Lisbon, London, manmade, marker, methodology, MFN, MHRA, Minnesota, MMC, motivating, move, myocardial, NaN, natriuretic, nausea, Neptune, neutrophil, nucleic, nurse, OIG, older, Ormond, overtly, overturned, pathology, PDUFA, peptide, perinatal, perspective, Petition, pharmacovigilance, Philadelphia, play, portal, pose, predecessor, principle, proceed, PRV, qui, quickly, ready, reconstitution, refinanced, regained, regimen, Rehearing, remitted, remotely, repay, reveal, revert, reward, route, Scotland, screening, sequelae, sequester, setup, shift, shut, situation, Spacecraft, spouse, spread, stably, stipulated, strain, strictly, subtitle, suspected, synthetic, talent, tam, taxation, temporarily, text, thrombocytopenia, timeframe, timeline, tooth, top, transaminase, Treasurer, trending, trick, UK, underwent, unearned, unqualified, upgrade, upholding, urge, viewpoint, virtual, visit, VP, Western, whistleblower, workplace, worsen
Removed:
adapted, al, auditory, bossing, Clustered, complicated, composition, correcting, counter, CRISPR, distract, donut, editing, efficiency, erythroid, expressing, foramina, fractional, frontal, harvesting, hepatosplenomegaly, hole, Hutch, immature, infancy, infringed, Interspaced, invalidation, ion, issuable, Jumpstart, macrocephaly, moiety, nerve, Palindromic, patented, people, prevailing, Prodigy, propensity, prosecuted, provoked, remedy, settled, Skull, spinal, sublicensing, suit, Suite, surrendered, surviving, thereon, Thoracic, traditional, unnecessary, waived, waiver, Wall
Filing tables
Filing exhibits
RCKT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement of Rocket Pharmaceuticals, Inc. on Form S-3 (Nos 333-251249 and 333-232168) and Form S-8 (Nos. 333-236946, 333-204501, 333-212308, 333-216892 and 333-223488) of our reports dated March 1, 2021, on our audits of the consolidated financial statements as of December 31, 2020 and 2019, and for each of the years in the three year period ended December 31, 2020, and the effectiveness of Rocket Pharmaceuticals, Inc.’s internal control over financial reporting as of December 31, 2020, which reports are included in this Annual Report on Form 10-K to be filed on or about March 1, 2021.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Philadelphia, Pennsylvania
March 1, 2021